NVLX Translational Drug Development or TD2 will conduct preclinical and clinical studies for Nuvilex that seem aimed at the overall management of pancreatic cancer (further explanation below) 
http: //finance.yahoo.com/news/nuvilex-investors-read-between-lines-130000508.html